Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Tumor Immunotherapy
1.2 Key Market Segments
1.2.1 Tumor Immunotherapy Segment by Type
1.2.2 Tumor Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Tumor Immunotherapy Market Overview
2.1 Global Market Overview
2.1.1 Global Tumor Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Tumor Immunotherapy Market Competitive Landscape
3.1 Global Tumor Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Tumor Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor Immunotherapy Sales Sites, Area Served, Product Type
3.6 Tumor Immunotherapy Market Competitive Situation and Trends
3.6.1 Tumor Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Tumor Immunotherapy Industry Chain Analysis
4.1 Tumor Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Tumor Immunotherapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Tumor Immunotherapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Tumor Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Tumor Immunotherapy Price by Type (2019-2024)
7 Tumor Immunotherapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Tumor Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor Immunotherapy Sales Growth Rate by Application (2019-2024)
8 Tumor Immunotherapy Market Segmentation by Region
8.1 Global Tumor Immunotherapy Sales by Region
8.1.1 Global Tumor Immunotherapy Sales by Region
8.1.2 Global Tumor Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Tumor Immunotherapy Basic Information
9.1.2 Roche Tumor Immunotherapy Product Overview
9.1.3 Roche Tumor Immunotherapy Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Tumor Immunotherapy SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Merck
9.2.1 Merck Tumor Immunotherapy Basic Information
9.2.2 Merck Tumor Immunotherapy Product Overview
9.2.3 Merck Tumor Immunotherapy Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Tumor Immunotherapy SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Novartis
9.3.1 Novartis Tumor Immunotherapy Basic Information
9.3.2 Novartis Tumor Immunotherapy Product Overview
9.3.3 Novartis Tumor Immunotherapy Product Market Performance
9.3.4 Novartis Tumor Immunotherapy SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Tumor Immunotherapy Basic Information
9.4.2 Johnson and Johnson Tumor Immunotherapy Product Overview
9.4.3 Johnson and Johnson Tumor Immunotherapy Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Tumor Immunotherapy Basic Information
9.5.2 GlaxoSmithKline Tumor Immunotherapy Product Overview
9.5.3 GlaxoSmithKline Tumor Immunotherapy Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 AbbVie
9.6.1 AbbVie Tumor Immunotherapy Basic Information
9.6.2 AbbVie Tumor Immunotherapy Product Overview
9.6.3 AbbVie Tumor Immunotherapy Product Market Performance
9.6.4 AbbVie Business Overview
9.6.5 AbbVie Recent Developments
9.7 ELI Lilly
9.7.1 ELI Lilly Tumor Immunotherapy Basic Information
9.7.2 ELI Lilly Tumor Immunotherapy Product Overview
9.7.3 ELI Lilly Tumor Immunotherapy Product Market Performance
9.7.4 ELI Lilly Business Overview
9.7.5 ELI Lilly Recent Developments
9.8 Amgen
9.8.1 Amgen Tumor Immunotherapy Basic Information
9.8.2 Amgen Tumor Immunotherapy Product Overview
9.8.3 Amgen Tumor Immunotherapy Product Market Performance
9.8.4 Amgen Business Overview
9.8.5 Amgen Recent Developments
9.9 AstraZeneca
9.9.1 AstraZeneca Tumor Immunotherapy Basic Information
9.9.2 AstraZeneca Tumor Immunotherapy Product Overview
9.9.3 AstraZeneca Tumor Immunotherapy Product Market Performance
9.9.4 AstraZeneca Business Overview
9.9.5 AstraZeneca Recent Developments
9.10 Bristol-Mysers Squibb
9.10.1 Bristol-Mysers Squibb Tumor Immunotherapy Basic Information
9.10.2 Bristol-Mysers Squibb Tumor Immunotherapy Product Overview
9.10.3 Bristol-Mysers Squibb Tumor Immunotherapy Product Market Performance
9.10.4 Bristol-Mysers Squibb Business Overview
9.10.5 Bristol-Mysers Squibb Recent Developments
9.11 Kite Pharma
9.11.1 Kite Pharma Tumor Immunotherapy Basic Information
9.11.2 Kite Pharma Tumor Immunotherapy Product Overview
9.11.3 Kite Pharma Tumor Immunotherapy Product Market Performance
9.11.4 Kite Pharma Business Overview
9.11.5 Kite Pharma Recent Developments
9.12 Adaptimmune
9.12.1 Adaptimmune Tumor Immunotherapy Basic Information
9.12.2 Adaptimmune Tumor Immunotherapy Product Overview
9.12.3 Adaptimmune Tumor Immunotherapy Product Market Performance
9.12.4 Adaptimmune Business Overview
9.12.5 Adaptimmune Recent Developments
9.13 Altor Bioscience Corporation
9.13.1 Altor Bioscience Corporation Tumor Immunotherapy Basic Information
9.13.2 Altor Bioscience Corporation Tumor Immunotherapy Product Overview
9.13.3 Altor Bioscience Corporation Tumor Immunotherapy Product Market Performance
9.13.4 Altor Bioscience Corporation Business Overview
9.13.5 Altor Bioscience Corporation Recent Developments
9.14 Cellectis
9.14.1 Cellectis Tumor Immunotherapy Basic Information
9.14.2 Cellectis Tumor Immunotherapy Product Overview
9.14.3 Cellectis Tumor Immunotherapy Product Market Performance
9.14.4 Cellectis Business Overview
9.14.5 Cellectis Recent Developments
9.15 Juno Therapeutics
9.15.1 Juno Therapeutics Tumor Immunotherapy Basic Information
9.15.2 Juno Therapeutics Tumor Immunotherapy Product Overview
9.15.3 Juno Therapeutics Tumor Immunotherapy Product Market Performance
9.15.4 Juno Therapeutics Business Overview
9.15.5 Juno Therapeutics Recent Developments
9.16 Takara Bio
9.16.1 Takara Bio Tumor Immunotherapy Basic Information
9.16.2 Takara Bio Tumor Immunotherapy Product Overview
9.16.3 Takara Bio Tumor Immunotherapy Product Market Performance
9.16.4 Takara Bio Business Overview
9.16.5 Takara Bio Recent Developments
9.17 Unum Therapeutics
9.17.1 Unum Therapeutics Tumor Immunotherapy Basic Information
9.17.2 Unum Therapeutics Tumor Immunotherapy Product Overview
9.17.3 Unum Therapeutics Tumor Immunotherapy Product Market Performance
9.17.4 Unum Therapeutics Business Overview
9.17.5 Unum Therapeutics Recent Developments
9.18 Sunway
9.18.1 Sunway Tumor Immunotherapy Basic Information
9.18.2 Sunway Tumor Immunotherapy Product Overview
9.18.3 Sunway Tumor Immunotherapy Product Market Performance
9.18.4 Sunway Business Overview
9.18.5 Sunway Recent Developments
9.19 Junshi Bio
9.19.1 Junshi Bio Tumor Immunotherapy Basic Information
9.19.2 Junshi Bio Tumor Immunotherapy Product Overview
9.19.3 Junshi Bio Tumor Immunotherapy Product Market Performance
9.19.4 Junshi Bio Business Overview
9.19.5 Junshi Bio Recent Developments
9.20 Cinda Bio
9.20.1 Cinda Bio Tumor Immunotherapy Basic Information
9.20.2 Cinda Bio Tumor Immunotherapy Product Overview
9.20.3 Cinda Bio Tumor Immunotherapy Product Market Performance
9.20.4 Cinda Bio Business Overview
9.20.5 Cinda Bio Recent Developments
9.21 BeiGene
9.21.1 BeiGene Tumor Immunotherapy Basic Information
9.21.2 BeiGene Tumor Immunotherapy Product Overview
9.21.3 BeiGene Tumor Immunotherapy Product Market Performance
9.21.4 BeiGene Business Overview
9.21.5 BeiGene Recent Developments
10 Tumor Immunotherapy Market Forecast by Region
10.1 Global Tumor Immunotherapy Market Size Forecast
10.2 Global Tumor Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Tumor Immunotherapy Market Size Forecast by Region
10.2.4 South America Tumor Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor Immunotherapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Tumor Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor Immunotherapy by Type (2025-2030)
11.1.2 Global Tumor Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor Immunotherapy by Type (2025-2030)
11.2 Global Tumor Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Tumor Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Tumor Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
